# US 2010/0137156 A1 · Construction and use of a functionally human antibody library with maximized repertoire diversity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0137156 A1
- Document ID: US20100137156A1
- Status: Published application
- Kind: A1
- Application number: 12/530,483
- Filed: 2008-03-10
- Published: 2010-06-03
- Earliest claimed: 2008-03-10
- Inventors: Shui-on Leung; Pui Fan Wong; Chi Wai Kwong; Yip Sum Chan
- Web page: https://patentgrep.com/patent/US20100137156A1

## CPC

- C07K 16/005: {constructed by phage libraries}
- C07K 16/241: {Tumor Necrosis Factors}
- C07K 2317/21: from primates, e.g. man
- C07K 2317/622: Single chain antibody (scFv)
- C07K 2317/74: Inducing cell proliferation
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Immunoglobulin libraries are provided that contain randomly assembled FR1, CDR1, FR2, CDR2, FR3, CDR3 and FR4 sequences of heavy or light chain immunoglobulin variable regions. The libraries exhibit a degree of repertoire diversity not found in natural immune systems and can be used to express novel immunoglobulins. The libraries can be used for screening antibodies with the target specificity of interest. The resultant antibodies can be fully human and non-immunogenic.

## Claims

### Claim 1

A method for producing a human immunoglobulin phage display library, the method comprising the steps of:
preparing a first set of nucleotide sequences, the sequences encoding human immunoglobulin light chain variable regions, wherein the sequences of said first set comprise sequences of human light chain cDNA segments encoding FR1, CDR1, FR2, CDR2, FR3, CDR3, and FR4, wherein the segments are randomly selected and ligated to encode a light chain variable region comprising in order FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4;
preparing a second set of nucleotide sequences, the sequences encoding human immunoglobulin heavy chain variable regions, wherein the sequences of said second set comprise sequences of human heavy chain cDNA segments encoding FR1, CDR1, FR2, CDR2, FR3, CDR3, and FR4, wherein the segments are randomly selected and ligated to encode a heavy chain variable region comprising in order FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4;
preparing a third set of nucleotide sequences, the sequences encoding single chain Fv immunoglobulins, wherein the sequences of said third set comprise a light chain sequence from said first set, a linker, and a randomly selected heavy chain sequence from said second set, wherein the linker covalently joins said light chain sequence and said heavy chain sequence such that the sequences of said third set encode single chain Fv immunoglobulins; and
incorporating the third set of nucleotide sequences into a phagemid cloning vector to form a phage display library.

### Claim 2 (depends on 1)

The method of claim 1, wherein said human light chain cDNA segments of said first set of nucleotide sequences encode only kappa chains.

### Claim 3 (depends on 1)

The method of claim 1, wherein said human light chain cDNA segments of said first set of nucleotide sequences encode only lambda chains.

### Claim 4 (depends on 1)

The method of claim 1, wherein said human light chain cDNA segments of said first set of nucleotide sequences encode both kappa and lambda chains.

### Claim 5 (depends on 1)

The method of claim 1, wherein said phage display library excludes the associations of FR1-CDR1-FR2-CDR2-FR3.

### Claim 6 (depends on 1)

The method of claim 1, wherein said human heavy chain cDNA segments of said second set of nucleotide sequences encode only gamma chains.

### Claim 7 (depends on 1)

The method of claim 1, wherein said human heavy chain cDNA segments of said second set of nucleotide sequences encode sequences of γ1, γ2, γ3, γ4, μ, α1, α2, δ, or ε heavy chains.

### Claim 8 (depends on 1)

A method of identifying an antigen binding molecule having binding specificity for a target antigen of interest comprising the steps of: (a) panning the human immunoglobulin phage display library of claim 1 for an immunoglobulin that appears to have a binding specificity for said target antigen; (b) expressing said immunoglobulin; and (c) testing the expressed immunoglobulin for binding to said target antigen.

### Claim 9 (depends on 1)

A human immunoglobulin phage display library produced by the method of claim 1.
